Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6

Journal Article · · Journal of Medicinal Chemistry
DOI:https://doi.org/10.1021/jm100571n· OSTI ID:1405005

Identification and structure-guided optimization of a series of 4-(pyrazol-4-yl)-pyrimidines as selective CDK4/6 inhibitors is reported herein. Several potency and selectivity determinants were established based on the X-ray crystallographic analysis of representative compounds bound to monomeric CDK6. Significant selectivity for CDK4/6 over CDK1 and CDK2 was demonstrated with several compounds in both enzymatic and cellular assays.

Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
USDOE Office of Science (SC)
OSTI ID:
1405005
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 22 Vol. 53; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
ENGLISH

Similar Records

Crystal structure of a human cyclin-dependent kinase 6 complexwith a flavonol inhibitor, Fisetin
Journal Article · Sun Jan 09 23:00:00 EST 2005 · Journal of Medicinal Chemistry · OSTI ID:860892

Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significiant in Vivo Antitumor Activity
Journal Article · Sat Dec 31 23:00:00 EST 2005 · Journal of Medicinal Chemistry · OSTI ID:930177

Discovery of 5-Amino- N -(1 H -pyrazol-4-yl)pyrazolo[1,5- a ]pyrimidine-3-carboxamide Inhibitors of IRAK4
Journal Article · Thu Jun 11 00:00:00 EDT 2015 · ACS Medicinal Chemistry Letters · OSTI ID:1404964